Synthetics Stance In NDI Guidance Raises Red Flag For Industry
This article was originally published in The Tan Sheet
FDA's draft guidance on new dietary ingredient notifications already is arousing fierce pushback from the supplement industry over what constitutes an NDI and which substances cannot be dietary ingredients at all.
You may also be interested in...
Herbalife asks FDA to temper its position that every supplement product containing a new dietary ingredient require a full notification, instead proposing a streamlined process based around NDI master files.
FDA should not use size alone to regulate nanotechnology, the Consumer Healthcare Products Association says.
FDA “grossly underestimated” firms’ costs for filing new dietary ingredient notifications and ignored their costs for substantiating claims, the Council for Responsible Nutrition says in July 25 comments.